We are deeply concerned that opposition to the use of QALYs could lead to broader proscriptions that could block any kind of value analysis, which would be a huge disservice to patients like me and millions of others who pay unjustified drug prices.
Drug companies raised the price of nearly 250 drugs since COVID-19 arrived in U.S.; 75 percent of those were drugs linked to COVID-19.
J&J and the rest of the pharmaceutical industry have seized on the coronavirus crisis as a way to polish an image tarnished by unaffordable medicine, patent lawsuits and an addiction epidemic.
"The price hike coincides with the company's push to get its drug to more patients — specifically those diagnosed with COVID-19."
The federal government will be the single largest investor and the largest purchaser of an upcoming COVID-19 vaccine or treatment.
We are writing to implore you to take urgent action to improve access to insulin products in light of the current COVID-19 pandemic.
New report shows an average increase of 5.6%
Council of Economic Advisers analysis puts politics over patients.
Patients For Affordable Drugs is the only independent national patient organization focused exclusively on achieving policy changes to lower the price of prescription drugs.
